Premature senescence in human breast cancer and colon cancer cells by tamoxifen-mediated reactive oxygen species generation

Life Sciences

Volumn 97, Issue 2, 2014, Pages 116-122

  Lee, Young Hoon ^a   Kang, Beom Sik ^a   Bae, Young Seuk ^a  

^a Kyungpook National University   (South Korea)

Author keywords

p53; Protein kinase CK2; ROS; Senescence; Tamoxifen

Indexed keywords

P53; PROTEIN KINASE CK2; ROS; SENESCENCE; TAMOXIFEN;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CASEIN KINASE II; CELL AGING; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HCT116 CELLS; HUMANS; REACTIVE OXYGEN SPECIES; TAMOXIFEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84894094517     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.12.009     Document Type: Article

References (37)

1. K.A. Ahmad, G. Wang, and K. Ahmed Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells Mol Cancer Res 4 2006 331 338
2. R. Battistutta, S. Sarno, E. De Moliner, E. Papinutto, G. Zanotti, and L.A. Pinna The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2 J Biol Chem 275 2000 29618 29622
3. M. Baum Adjuvant endocrine therapy in postmenopausal women with early breast cancer: where are we now? Eur J Cancer 41 2005 1667 1677
4. V.P. Bindokas, J. Jordan, C.C. Lee, and R.J. Miller Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine J Neurosci 16 1996 1324 1336
5. W.O. Carter, P.K. Narayanan, and J.P. Robinson Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells J Leukoc Biol 55 1994 253 258
6. 2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication Biochem J 332 1998 43 50
7. S. Desagher, A. Osen-Sand, S. Montessuit, E. Magnenat, F. Vilbois, and A. Hochmann et al. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8 Mol Cell 8 2001 601 611
8. G.P. Dimri, X. Lee, G. Basile, M. Acosta, G. Scott, and C. Roskelley et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo Proc Natl Acad Sci U S A 92 1995 9363 9367
9. M.J. Duffy Predictive markers in breast and other cancers Clin Chem 51 2005 494 503
10. J.S. Duncan, and D.W. Litchfield Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2 Biochim Biophys Acta 1784 2008 33 47
11. R.A. Faust, M. Gapany, P. Tristani, A. Davis, G.L. Adams, and K. Ahmed Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation Cancer Lett 101 1996 31 35
12. S. Goldstein Replicative senescence: the human fibroblast comes of age Science 249 1990 1129 1133
13. D.E. Hanna, A. Rethinaswamy, and C.V. Glover Casein kinase II is required for cell cycle progression during G1 and G2/M in Saccharomyces cerevisiae J Biol Chem 270 1995 25905 25914
14. S.M. Jeon, S.J. Lee, T.K. Kwon, K.J. Kim, and Y.S. Bae NADPH oxidase is involved in protein kinase CKII down-regulation-mediated senescence through elevation of the level of reactive oxygen species in human colon cancer cells FEBS Lett 584 2010 3137 3142
15. Cip1/WAF1 pathway is necessary for cellular senescence induced by the inhibition of protein kinase CKII in human colon cancer cells Mol Cells 28 2009 489 494
16. M. Katsuyama NOX/NADPH oxidase, the superoxide-generating enzyme: its transcriptional regulation and physiological roles J Pharmacol Sci 114 2010 134 146
17. M.S. Kim, Y.T. Lee, J.M. Kim, J.Y. Cha, and Y.S. Bae Characterization of protein interaction among subunits of protein kinase CKII in vivo and in vitro Mol Cells 8 1988 43 48
18. A. Krippner-Heidenreich, R.V. Talanian, R. Sekul, R. Kraft, H. Thole, and H. Ottleben et al. Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1 Biochem J 358 2001 705 715
19. E.A. Kuenzel, and E.G. Krebs A synthetic peptide substrate specific for casein kinase II Proc Natl Acad Sci U S A 82 1985 737 741
20. E. Landesman-Bollag, R. Romieu-Mourez, D.H. Song, G.E. Sonenshein, R.D. Cardiff, and D.C. Seldin Protein kinase CK2 in mammary gland tumorigenesis Oncogene 20 2001 3247 3257
21. K.Y. Lin, C. Tai, J.C. Hsu, C.F. Li, C.L. Fang, and H.C. Lai et al. Overexpression of nuclear protein kinase CK2α catalytic subunit (CK2α) as a poor prognosticator in human colorectal cancer PLoS One 6 2011 e17193
22. S. Mandlekar, and A.N. Kong Mechanisms of tamoxifen induced apoptosis Apoptosis 6 2001 469 477
23. P. Moreira, J. Custodio, A. Morena, C. Oliveira, and M. Santos Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure J Biol Chem 281 2006 10143 10152
24. E.A. Musgrove, and R.L. Sutherland Biological determinants of endocrine resistance in breast cancer Nat Rev Cancer 9 2009 631 643
25. J.M. Nigro, S.J. Baker, A.C. Preisinger, J.M. Jessup, R. Hostetter, and K. Cleary et al. Mutations in the p53 gene occur in diverse human tumour types Nature 342 1989 705 708
26. P.M. O'Connor, J. Jackman, I. Bae, T.G. Myers, S. Fan, and M. Mutoh et al. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth inhibitory potency of 123 anticancer agents Cancer Res 57 1997 4285 4300
27. R.B. Riggins, R.S. Schrecengost, M.S. Guerrero, and A.H. Bouton Pathways to tamoxifen resistance Cancer Lett 1 2007 1 24
28. INK4a enrichment and the premature senescence of normal fibroblasts Oncogene 16 1998 1113 1123
29. M. Ruzzene, and L.A. Pinna Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim Biophys Acta 1804 2010 499 504
30. S.W. Ryu, J.H. Woo, Y.H. Kim, Y.S. Lee, J.W. Park, and Y.S. Bae Down-regulation of protein kinase CKII is associated with cellular senescence FEBS Lett 580 2006 988 994
31. S. Sarno, E. De Moliner, M. Ruzzene, M.A. Pagano, R. Battistutta, and J. Bain et al. Biochemical and three-dimensional structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin- 7-yl]acetic acid (IQA) Biochem J 374 2003 639 646
32. C.C. Schneider, A. Hessenauer, C. Götz, and M. Montenarh DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks Oncol Rep 21 2009 1593 1597
33. D.C. Seldin, and P. Leder Casein kinase IIα transgene-induced murine lymphoma: relation to theileriosis in cattle Science 267 1995 894 897
34. INK4a Cell 88 1997 593 602
35. G. Stalter, S. Siemer, E. Becht, M. Ziegler, K. Remberger, and O.G. Issinger Asymmetric expression of protein kinase CK2 subunits in human kidney tumors Biochem Biophys Res Commun 202 1994 141 147
36. M. Tewari, L.T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, and D.R. Beidler et al. Yama/CPP32, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase Cell 81 1995 801 809
37. J. Zhu, D. Woods, M. McMahon, and J.M. Bishop Senescence of human fibroblasts induced by oncogenic Raf Genes Dev 12 1998 2997 3007